Collectively, in the largest cohort of adult B-ALL patients (106 BCR-ABL1 positive and 38 B-NEG) reported so far we detected deletions of IKZF1 gene in 71% B-ALL cases with a variable pattern of breakpoints. This evidence concerns the gene IKZF1 and acute lymphoblastic leukemia.